Data from the 1999-2018 National Health and Nutrition Examination Survey were used to analyze the prevalence of social determinants of health (SDOH) among patients with self-reported heart failure (HF).
Social determinants of health (SDOH) are unequally distributed among ambulatory individuals who are living with heart failure (HF) when their income level and racial background are considered, according to a new analysis of 1999-2018 National Health and Nutrition Examination Survey data by a team from UT Southwestern Medical Center.
The poster containing this analysis’ findings was presented at the recent American Society for Preventive Cardiology’s Congress on CVD Prevention, held in Arlington, Texas, July 21-23.
“Outcomes in HF patients are modified by their burden of SDOH. There is no data on national prevalence of SDOH among ambulatory HF patients,” the authors wrote. “We aimed to fill this gap by evaluating national prevalence of SDOH among ambulatory HF patients across racial, ethnic, and income groups.”
In addition to income level and race/ethnicity categories, environmental factors and health status were evaluated for their influence as SDOH on HF-related outcomes. The study population comprised 1906 patients representing a weighted 5.25 million individuals in the United States.
An overall 81.4% of the study population (n = 4,275,684) is burdened by at least 2.1 SDOH, according to the investigators, who considered the effects of 5 categories of SDOH in their study: 0, 1, 2, 3, and 4. The fewest patients overall (n = 115,595) were not burdened by any SDOH, while the most in any category was 2.9 million patients (55.0%) reporting 2 SDOH. In addition, 862,500 (16.4%) had a burden of 1 SDOH; 1,268,782 (24.2%) had a burden of 3 SDOH; and 117,461 (2.2%), 4 SDOH.
The mean patient age was 66.3 years, and most patients were male (51.7%), White (71.8%), and had self-reported incomes between 130% and 350% of the federal poverty level (FPL). Of the remaining study population, 14.7% were Black, 8.2% were Hispanic, 5.3% were Asian/Other, 33.7% reported an income below 130% of the FPL, and 20.9% self-reported an income above 350% of the FPL.
Patients reporting incomes below 130% of the FPL were burdened by a higher mean total of SDOH domains compared with the individuals reporting an income between 130% and 350% of the FPL and above 350% of the FPL: 2.5 vs 2.0 vs 1.6, respectively. In addition, Hispanic patients reported the highest mean total of SDOH domains among the race/ethnicity populations, at 2.4, compared with 2.3 among Black patients, 2.2 among Asian/Other patients, and 2.0 among White patients.
Delving deeper for individual SDOH, race/ethnic difference were also seen for the following SDOH (all P < .0001):
There were also discrepancies seen according to overall income level (all P < .01):
The study investigators underscore the need for future research to focus on social interventions that can aid in modifying the effects of SDOH to improve outcomes among patients living with HF, due to the uneven distribution they saw in their analysis by income and race/ethnicity.
Reference
Patel L, Lokesh N, Rao S, Powell-Wiley T, Sumarsono A. Prevalence of social determinants among US residents with heart failure by race/ethnicity and household income. Presented at: ASPC Congress on CVD Prevention; July 21-23, 2023; Arlington, Texas. Poster 114.
AI in Health Care: Closing the Revenue Cycle Gap
April 1st 2025This commentary explores the current state, challenges, and potential of artificial intelligence (AI) in health care revenue cycle management, emphasizing collaboration, data standardization, and targeted implementation to enhance adoption.
Read More
Financial, Housing, Food Insecurity Raises Risk of Hospital, ED Visits
April 1st 2025Social determinants of health been long understood to influence health outcomes, and this new analysis explores more deeply the link between social risk exposure and rates of health care resource utilization.
Read More
Politics vs Science: The Future of US Public Health
February 4th 2025On this episode of Managed Care Cast, we speak with Perry N. Halkitis, PhD, MS, MPH, dean of the Rutgers School of Public Health, on the public health implications of the US withdrawal from the World Health Organization and the role of public health leaders in advocating for science and health.
Listen
MINT Trial 26-Week Data Show Inebilizumab for gMG Is Effective and Safe
April 1st 2025These are data to week 26 on the monoclonal antibody and antineoplastic agent; data out to week 52 of the MINT trial will be presented in a late-breaking oral session at the upcoming American Academy of Neurology Annual Meeting.
Read More
AI in Health Care: Closing the Revenue Cycle Gap
April 1st 2025This commentary explores the current state, challenges, and potential of artificial intelligence (AI) in health care revenue cycle management, emphasizing collaboration, data standardization, and targeted implementation to enhance adoption.
Read More
Financial, Housing, Food Insecurity Raises Risk of Hospital, ED Visits
April 1st 2025Social determinants of health been long understood to influence health outcomes, and this new analysis explores more deeply the link between social risk exposure and rates of health care resource utilization.
Read More
Politics vs Science: The Future of US Public Health
February 4th 2025On this episode of Managed Care Cast, we speak with Perry N. Halkitis, PhD, MS, MPH, dean of the Rutgers School of Public Health, on the public health implications of the US withdrawal from the World Health Organization and the role of public health leaders in advocating for science and health.
Listen
MINT Trial 26-Week Data Show Inebilizumab for gMG Is Effective and Safe
April 1st 2025These are data to week 26 on the monoclonal antibody and antineoplastic agent; data out to week 52 of the MINT trial will be presented in a late-breaking oral session at the upcoming American Academy of Neurology Annual Meeting.
Read More
2 Commerce Drive
Cranbury, NJ 08512